Atlas Trials

Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures

Clinical trial NCT03336242 · TERMINATED

Trial details

NCT number
NCT03336242
Sponsor
Radius Pharmaceuticals, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Childhood Absence Epilepsy
Start date
2017-12-29
Primary completion
2019-05-15
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.